Skip to Main Content

Keeping you informed

Parker Poe Ranked Among Leading National Firms for Patent Litigation Involving Generic Drugs

  • September 29, 2020

Charlotte, N.C. – Parker Poe Adams & Bernstein LLP is pleased to announce that Patexia Inc., an intellectual property analytics company, has ranked the firm and four of its attorneys among the best in the country for Abbreviated New Drug Application (ANDA) litigation. These cases fall under the Hatch-Waxman Act and involve patents for generic drugs. 

Parker Poe ranked as the ninth best performing law firm representing defendants out of the 91 defendants’ firms considered. Parker Poe maintained a high level of quality despite also having one of the most active Hatch-Waxman practices (tied for 18th in overall cases for defendants).

Patexia also ranked three Parker Poe attorneys among the 60 best performing ANDA litigators representing defendants:

  • Elizabeth Crompton
  • Scott Cunning
  • Robert Florence

Parker Poe has been serving life sciences clients for more than 35 years. Today, the firm’s Life Sciences Team includes patent attorneys from Atlanta to Washington and represents some of the top pharmaceutical, biotechnology, and medical device companies in the world. It also regularly advises clinical laboratories, government and nonprofit research organizations, entrepreneurs, and scientists.

About Parker Poe
Parker Poe Adams & Bernstein LLP has more than 225 lawyers in eight offices in North Carolina, South Carolina, Georgia, and Washington, D.C. The firm provides legal counsel to many of the largest companies and local governments in the Southeast.

Parker Poe is a member of two leading international legal networks: TerraLex and the Employment Law Alliance. TerraLex and the ELA have chosen Parker Poe to help guide clients through the challenges of global business.